Beam Therapeutics BEAM Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's total liabilities?
- Beam Therapeutics (BEAM) reported total liabilities of $316.36M in Q1 2026.
- How has Beam Therapeutics's total liabilities changed year-over-year?
- Beam Therapeutics's total liabilities decreased by 8.0% year-over-year, from $343.78M to $316.36M.
- What is the long-term trend for Beam Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Beam Therapeutics's total liabilities has grown at a 3.3% compound annual growth rate (CAGR), from $206.12M to $242.82M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.